Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, and Chronic Obstructive Pulmonary Disease (COPD) Research.
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry
Pulmonary Hypertension in Patients With COPD
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
Risk assessment in pulmonary arterial hypertension
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Loss-of-Function <i>ABCC8</i> Mutations in Pulmonary Arterial Hypertension
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
A global view of pulmonary hypertension
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research†
Left ventricular heart failure and pulmonary hypertension
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
U.S.-Belize Cooperative Research: Muds and Pollution in Belize Rivers
EPWG: The Turnage Science, Math and Technology Scholars Program
Acquisition of High Field Nuclear Magnetic Resonance Spectrometer for Transport Studies
NSF-NATO Postdoctoral Fellow
Geochemical Study of the Ganges Brahmaputa Rivers, Develop- ment of Joint Proposal, Travel Award in Indian Currency.
An Atomic Absorption Spectrometer for Undergraduate Environmental Studies in Biology and Chemistry
RUI: Acquisition of a Circular Dichroism Spectrometer
Workshop and Report on River Interaction With the Ocean, Rio